ClinLab Navigator Logo
November 2014 Newsletter 
In This Issue
NEW Mobile Apps Available
Restrictive Transfusion Strategy Reduces Risk of Healthcare Associated Infection
Lower Transfusion Thresholds do not Harm Septic Shock Patients
Website Updates
--------------------------------------------

New Articles This Month
 


.......................................................... 
--------------------------------------------

Updated Articles This Month
 
..........................................................
--------------------------------------------

Visit Our Sponsor
Professional Co-op logo


--------------------------------------------

Featured Interview
An Interview with Dr  Fred Plapp, Author of www.ClinLabNavigator.com
An Interview with Dr Fred Plapp, Author of www.ClinLabNavigator.com

-------------------------------------------

 

Essentials of Transfusion Medicine
by Fred V. Plapp MD PhD by BookSurge Publishing
Paperback ~ Release Date: 2008-08-18
List Price: $25.95
Our Price: $20.83
Buy Now

 

-------------------------------------------

 

Know Someone Who Might Enjoy Our Mailing List?


-------------------------------------------

 

Interact With Us

Find us on Facebook

Follow us on Twitter


View our profile on LinkedIn 
ClinLab Navigator Logo


facebook Page!
Facebook Like
Find us on facebook
Never miss an update or new article!

Click on the image to the right to visit our facebook page and like ClinLab Navigator.


About Us
For the latest information and updates, please visit our website at:  www.clinlabnavigator.com.

 

Sincerely,

 

Chris Plapp

ClinLab Navigator LLC

 

iBook Available
iBook

Our well received book is now available in the iBook format for your iPad.

Click on the image to the right to view the book in the iTunes store.
 
New Lower Price:
$9.99



Thank you for your interest in ClinLab Navigator.  You are receiving this e-mail because you registered on our web site. 
 
We hope you will find this monthly newsletter helpful.  Please send us any suggestions or feedback.

ClinLab Navigator
Mobile

NEW Mobile Applications are now available for Download!  This is a BRAND NEW application, not an update.

Please delete your previous version and download the new version using the link below.
 
Get it Now:  iPhone Version  | iPad Version 


 
Have Any Suggestions?
 
If you have any suggestions to make our apps even better, please don't hesitate to contact us at:  [email protected]

 

Restrictive Transfusion Strategy Reduces Risk of Healthcare Associated Infection 

 

The association between transfusion strategies and healthcare-associated infection was recently assessed in a meta-analysis that included 18 randomized trials with a total 7,593 patients that were assigned to either a restrictive or liberal transfusion strategy. The definition of restrictive and liberal transfusion strategies varied amongst individual studies, but most defined a restrictive strategy as the transfusion of red blood cells once hemoglobin falls below either 7.0 or 8.0 grams per deciliter and a liberal strategy as transfusion once hemoglobin falls below 10 grams per deciliter.


 

The main outcomes of these studies were serious healthcare-associated infections such as pneumonia, mediastinitis, wound infection, and sepsis. The pooled risk of all serious infections was 11.8% in patients treated under a restrictive strategy and 16.9% in patients treated under a liberal strategy. Risk ratio for the association between transfusion strategies and serious infection was 0.82 (95% CI 0.72-0.95). The number needed to treat with a restrictive strategy to avoid one infection was 38 (Rohde JM, et al. JAMA 2014; 311(13): 1317-1326). In the subset of those studies with the most restrictive hemoglobin strategy of <7.0 g/dL, risk ratio remained at 0.82, but the number needed to treat decreased to 20.

 

When the analysis was stratified by patient type, researchers found that a restrictive strategy in patients undergoing orthopedic surgery and in patients presenting with sepsis significantly reduced the chance of infection, with risk ratios of 0.70 and 0.51, respectively. There were no significant differences in the incidence of infection by hemoglobin threshold for patients with cardiac disease, the critically ill, those with acute upper gastrointestinal bleeding, or low birth weight infants.


 

More than 80% of patients in this meta-analysis were transfused with leukocyte reduced red blood cells, which are believed to reduce the risks of transfusion associated immunomodulation.


 

About one in every 20 inpatients develops a nosocomial infection, with estimated annual direct medical costs to U.S. hospitals ranging between $28 billion and $45 billion. Transfusion is associated with immunomodulation, which may affect infection risk. This meta-analysis suggests that adoption of restrictive transfusion strategies might prevent 26 healthcare-associated infections for every 1000 patients in which red blood cell transfusion is under consideration.  

 

 

Lower Transfusion Thresholds do not Harm Septic Shock Patients 

 

An international, multicenter, randomized trial recently assessed the best transfusion threshold for 998 critically ill patients with septic shock (Holst etal. NEJM 2014;37:1381). Patients in the ICU were randomized to receive 1 unit of leukocyte reduced red blood cells when the hemoglobin was 7 g/dL or less (restrictive group) or when the hemoglobin was 9 g/dL or less (liberal group). The restrictive group received a median of 1 unit of blood, while the liberal group received a median of 4 units.

 

By 90 days after randomization, 43% (216/502) of patients in the restrictive transfusion group had died compared to 45% (223/496) of the liberal transfusion group (relative risk, 0.94; 95% confidence interval, 0.78-1.09). There was no difference in mortality, the number of ischemic events, severe adverse reactions, or numbers of days in the hospital between patients in the restrictive group (7 g/dL) compared to those in the liberal group (9 g/dL). A restrictive transfusion strategy not only reduced blood use by half but also did not cause harm.

 

News
ClinLab Navigator
Site Updates
 
Click on the image below to view our site.
Visit our new site!
 
Have Any Suggestions?
 
If you have any suggestions to make our site even better, please don't hesitate to contact us at:  [email protected]

 


(Sponsor this newsletter)